Long Covid: Study of Quality of Life, Clinical Evolution and Use of Care. Cohort in General Practice and General Population in Metropolitan France COVILEV Study

Brief summary (registry, in English)

The term "long COVID" refers to persistent, recurrent, or newly emerging symptoms following a biologically confirmed or suspected case of COVID-19 that are still present three months after the acute episode or positive test result, and that cannot be explained by a complication of the acute phase, a flare-up of a comorbid condition, or any cause other than COVID-19. The incidence of long Covid has primarily been estimated through the follow-up of cohorts of patients initially treated in the hospital, sometimes based on cohorts of patients who consulted a primary care physician, and rarely based on cohorts of individuals from an unselected source population who tested positive for Covid-19. Currently, there is little data available to estimate its overall burden in primary care and the general population (prevalence, incidence, healthcare utilization, symptom progression, and impact on quality of life). This study will consist of two arms: "general practice" and "general population." For each arm, an initial phase will involve simply counting cases, and a second phase will involve describing and monitoring cases over the course of one year, focusing on clinical outcomes, quality of life, and the patient care experience. The "general practice" arm will also include a study of the care experience from the perspective of general practitioners. Statistical analysis. For each arm of the study, the included patients will be described in terms of the various aspects under investigation: sociodemographic characteristics, history of COVID-19 infection, clinical presentation, quality of life, and psychological, professional, and family impact. The incidence and prevalence of cases seen in general practice will be estimated. Expected results and implications. The study will provide a better understanding of the disease and its impact, including for people who do not seek care for this reason. It will provide information to guide public policies regarding the care and treatment pathways for people suffering from long COVID.

What you commit to

• Study type: Interventional
• Participants enrolled: 618
• From 6 Jun 2023 to the primary completion date, 30 Jul 2024
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.